Tag: EML4-ALK; ALK,Press Releases,blood-based cancer test,liquid biopsy; NSCLC,lung cancer
-
Biodesix’ GeneStrat Blood-Based Mutation Test Now Includes EML4-ALK Fusions
EGFR sensitizing, EGFR T790M, EML4-ALK, KRAS, and BRAF; 72 hour Turnaround Time to Results